Mahamaya Lifesciences
Listing performance
Scheduled dates
Tentative timetable — a past date is not confirmation the step completed
Grey market premium
Unofficial and indicative — not a forecast
3 observations recorded — too few to plot a trend.
Day-wise premium · 3 observations
| Date | GMP | % | Sauda | Est. listing | Gain / lot |
|---|---|---|---|---|---|
| 18 Nov 2025 | ₹0 | 0.00% | ₹0 | ₹114 | ₹0 |
| 17 Nov 2025 | ₹0 | 0.00% | ₹0 | ₹114 | ₹0 |
| 16 Nov 2025 | ₹0 | 0.00% | ₹0 | ₹114 | ₹0 |
Gain per lot assumes the premium holds to listing and that the application is allotted — allotment in an oversubscribed issue is a lottery, so it is indicative, not expected. Sauda is the rate paid for a submitted application itself.
Issue details
- IPO date
- 11 Nov 2025 – 13 Nov 2025
- Listing date
- 18 Nov 2025
- Face value
- ₹1 per share
- Issue price
- ₹114 per share
- Lot size
- 1,200 shares
- Issue type
- Book Building issue
- Listing at
- BSE
- Total issue size
- ₹70.44 Cr
- Market cap at offer price
- ₹267 Cr
- Promoter holding
- 77.27% → 56.35% pre-issue → post-issue
- ISIN
- INE0U9D01019
- Registrar
- Kfin Technologies Ltd.
- Lead managers
- Oneview Corporate Advisors Pvt.Ltd.
- Registered office
- Unit No: DPT 033, Ground Floor, Plot No: 79 80, DLF Prime Tower, Block, Okhla, Phase-1, New Delhi
Reservation and application size
How the issue is split between investor categories, and what each may bid
| Investor category | Shares | % of net | % of total |
|---|---|---|---|
| Anchor investor · within QIB | 17,52,000 | — | — |
| Market maker | 3,09,600 | — | — |
Application size
Minimum 1,200 shares per lot, in multiples, at ₹114
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (min) | 1 | 1,200 | ₹1,36,800 |
| S-HNI (min) | 2 | 2,400 | ₹2,73,600 |
| S-HNI (max) | 7 | 8,400 | ₹9,57,600 |
| B-HNI (min) | 8 | 9,600 | ₹10,94,400 |
Category limits
| Category | Bid size | Cut-off |
|---|---|---|
| Retail (RII) | Up to ₹2 lakh | Yes |
| Small HNI (sNII) | ₹2 lakh – ₹10 lakh | No |
| Big HNI (bNII) | Above ₹10 lakh | No |
| Employee | Up to ₹5 lakh | Yes |
Bidding at cut-off means accepting the final issue price without naming one. Only retail and employee applicants may do so.
Anchor investors
Institutional allocation placed a day before the issue opens, carved out of the QIB portion and locked in after listing.
Valuation and performance
Valuation at offer price
₹114 per share
| Metric | Pre-issue | Post-issue |
|---|---|---|
| EPS (₹) | 7.29 | 7.01 |
| P/E (×) | 15.64 | 16.26 |
| Price to book (×) | 9.40 | — |
| Market cap | — | ₹267 Cr |
Key performance indicators
Latest reported period
- Return on net worth
- 26.19%
- ROCE
- 23.15%
- Debt / equity
- 1.08
- PAT margin
- 4.84%
- EBITDA margin
- 9.22%
- NAV per share
- ₹12.13
- Price to book
- 9.40
Single period as reported. Year-on-year movement is in the financials table below, where every period is published.